The customer applied for a reimbursement extension (new indication) in Belgium for one of their pharmaceutical products for the treatment of Hodgkin Lymphoma. The customer has asked Hict for support of this reimbursement submission, specifically data collection of expert opinion via a survey and a consensus meeting.
Main Goal: Data collection of Belgian-specific data
Main Result: Survey & consensus meeting resulting in report with validated Belgian data
This support includes
The consensus meeting was designed to provide an answer to strategic questions in the context of the reimbursement submission and launch of the product in Belgium: Who are the patients for whom the product would add the most value in Belgium within the target population (label)?
The following research questions were defined:
Hict’s approach consisted of the following two main phases:
Phase 1 – Intake phase
During the intake phase, the context, strategy and key parameters of the submission are discussed and analyzed. The proposed data collection approach is finetuned and finalized in cooperation with the customer.
Phase 2 – Data collection
Based on the data collection approach discussed and validated during the intake phase, the data collection protocol is executed during the data collection phase.
The following approach is provided for the data collection: